RiverVest Venture Fund IV, L.P.

Insider Reports History

Location
St. Louis, MO
Signature
/s/ Jay Schmelter, Manager of RiverVest Venture Partners IV, LLC
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by RiverVest Venture Fund IV, L.P.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xilio Therapeutics, Inc. 10%+ Owner Common Stock 1,441,444 $1,196,399 $0.8300 26 Oct 2021 Indirect
Xilio Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 26 Oct 2021 Indirect

Insider Reports Filed by RiverVest Venture Fund IV, L.P.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XLO Xilio Therapeutics, Inc. 26 Oct 2021 5 +$4,000,000 4 10%+ Owner 26 Oct 2021, 17:30
XLO Xilio Therapeutics, Inc. 21 Oct 2021 0 $0 3 10%+ Owner 21 Oct 2021, 20:40